- 4009 Hackney Springs Ln, Sachse, TX 75048
Your Lab May Be Losing Money Right Now!
Find out fast with a
No-Cost Revenue Audit.
Louisiana labs face a tough billing landscape where state law §37:1742 flatly bans physicians who didn’t perform or supervise anatomic pathology services from billing, a far stricter rule than the federal anti-markup cap. Any claim routed through an unqualified practitioner invites license actions, denied payments, and CMS scrutiny. Simultaneously, §37:1741 demands transparent disclosure of the performing lab’s name, address, and exact amount paid. The key is ensuring only the performing pathologist bills for these services, regularly auditing referral arrangements, and checking that every claim satisfies both state and federal requirements.
Partnering with a Louisiana-focused lab billing company, like TransLabs, that masters these dual-layer mandates eliminates physician middleman schemes, keeps claims compliant, and protects your revenue so your team can focus on accurate diagnostics.
Suppose a patient’s biopsy sample takes a strange detour before it reaches the lab that reads it. The referring physician bills for the service, charges extra for additional services that a patient never asked for, and the patient doesn’t know that a middleman exists. This is how physicians operated in Louisiana for years until Louisiana discontinued the practice years ago. The new pathology direct billing mandates by the state shape the way how a lab bills for Louisiana specimens.
Want to know how that works? Here, we’ll discuss the requirements of the statute on who can submit the claim and what the penalties are for someone who violates the rules. Further, we’ll also guide you on managing the complex issue with end-to-end pathology lab billing services across The Pelican State. So, let’s discuss that in detail.
Louisiana Revised Statute §37:1742, the Direct Billing of Anatomic Pathology Services, part of the state’s professions code, regulates how pathology billing claims are processed in Louisiana. This law states that unless a physician (medicine, dentistry, optometry, podiatry, or chiropractic) personally performed or directly supervised an outpatient anatomic pathology service, that physician cannot charge, bill, or even ask for payment for it.
And if a healthcare practitioner is officially licensed as a pathologist in Louisiana, they can bill the claim. Under this law, they can send the bill only to four parties:
No other entity is allowed to bill for pathology services. If a practitioner violates the law, the state licensing board can revoke, suspend, or refuse to renew their license. On top of that, patients, insurers, and clinics aren’t even required to pay a bill that violates the statute.
Further, the law doesn’t stop lab-to-lab billing when a sample gets referred out to another specialist. So reference lab arrangements between two labs remain fair to use, as long as a physician middleman doesn’t try to charge for a cut.
§37:1742 doesn’t apply on its own. It works with Revised Statute §37:1741, the law for disclosure of fees for laboratory services.
According to it, if a licensed physician, dentist, optometrist, podiatrist, veterinarian, or chiropractor arranges with a laboratory to run tests and then folds that cost into their own bill to the patient, the practitioner must disclose two things right there on the bill:
With that, the patient knows what they’re paying for.
But now, the confusion is how the two laws work together. While §37:1742 flatly bans certain billing arrangements for anatomic pathology, §37:1741 forces honesty in situations involving general lab testing where billing between a physician and a lab is still permitted. Together, these two laws prevent referring physicians from profiting from tests they haven’t performed.
The concept is simple: the lab that performs the test is paid for it fairly, and a practitioner is clear about the amount they’re charging to the patient.
Before direct billing laws existed in states like Louisiana, a referring physician could order a pathology test, mark it up, and pocket the difference. That setup created an obvious problem: physicians had a financial reason to order more tests than were medically necessary. More orders meant more markup income. And physicians followed that practice to order services where they could financially benefit.
Institutions, like the College of American Pathologists (CAP), have advocated for direct billing laws across roughly 20 states for exactly this reason. Their position is simple. When a referring physician profits from a pathologist’s diagnostic work, it creates a conflict of interest and interferes with the direct relationship between the pathologist and the patient.
This is why Louisiana stepped in to prevent a referring practice from marking up a lab bill, something which patients aren’t aware of.
Louisiana’s disclosure and direct-billing statutes were designed to prohibit that, whether by banning the arrangement outright (§37:1742) or by requiring full disclosure when billing between providers is still allowed (§37:1741).
Following Louisiana’s direct billing mandates is the right approach to stay on the right side of the law. However, considering federal law is also important, as a violation poses bigger risks.
The anti-markup rule pathology billers deal with at the federal level comes from 42 C.F.R. § 414.50, administered by the Centers for Medicare & Medicaid Services (CMS). This regulation restricts the amount a billing physician may charge Medicare for the technical component or professional component of a diagnostic test when the performing physician does not share a practice with the billing physician.
In practice, if a physician orders a test from an external pathologist and the arrangement does not meet CMS’s practice-sharing criteria, the billing physician is prohibited from adding a markup. Payment is instead limited to the lowest of several benchmarks specified by CMS.
Louisiana’s law goes further for anatomic pathology specifically. It doesn’t just cap what a referring physician can charge; it removes the referring physician from the billing chain completely for those services. Here’s a side-by-side to make the contrast clear:
| Feature | Louisiana §37:1742 (State) | 42 CFR §414.50 (Federal) |
|---|---|---|
| Scope | Outpatient anatomic pathology services | Diagnostic tests billed to Medicare (TC and PC) |
| Approach | Bans non-performing physicians from billing at all | Caps payment amount, doesn't ban the arrangement |
| Who can bill | Only the performing/supervising pathologist, per the approved list | Billing physician can still bill, just at a capped rate |
| Applies to | Louisiana-licensed practitioners | Medicare-participating providers nationwide |
| Enforcement | State licensing board action, denial of reimbursement | CMS payment reduction, program integrity review |
If your lab has referral relationships with physician offices, use laboratory billing audit services to periodically check that no one downstream is billing for work they didn’t perform or supervise.
Louisiana’s pathology billing rules are complex because you have to follow both state and federal laws. The state’s direct billing mandate (§37:1742) completely stops physicians who didn’t perform or supervise the test from billing for anatomic pathology services, something the federal rule doesn’t do. At the same time, §37:1741 demands clear disclosure of the lab’s name, address, and the exact amount paid on any bill. If a claim is routed through the wrong party, it can lead to license actions, denied payments, and CMS scrutiny.
Outsourcing Louisiana laboratory billing services to a partner like TransLabs is the right step here. Doing so makes sure every claim follows both sets of rules, removes physician middleman schemes, and keeps your revenue safe while your team focuses on accurate diagnostics.
Louisiana’s pathology direct billing law is plain and simple. If a physician didn’t personally perform or directly supervise an outpatient anatomic pathology service, that physician can’t bill it. When you pair that with the state’s cost disclosure requirement for general lab testing, practitioners need to be honest about disclosing who performed the service and what they charged.
For labs and billing teams, it shapes claim routing, referral agreements, and compliance training. A compliance violation can lead the state to revoke the license and deny claims. If you get it right, your revenue cycle runs cleaner, with far less risk hanging over every claim tied to a Louisiana patient. You can do that when your lab chooses the right billing partner, who masters state-specific pathology and lab compliance.
